Last Updated on July 14, 2021 by The Health Master
FDC has launched oral suspension of Favipiravir to treat mild to moderate cases of C-19 in the country.
This prescription-only Favenza oral suspension is currently available at all retail medical outlets and hospital pharmacies across India, FDC said in a statement.
Convenient loading dosage of the oral suspension helps reduce dosage frequency, it added.
“With positive cases on the rise again, now is the time to provide healthcare warriors in our country with viable options in this continuous battle against this disease.
In order to combat C-19, we believe in offering best efficacy along with convenience to our patients and as such we have focused our efforts in making the process of C-19 treatment hassle-free,” said Mayank Tikkha, General Manager – Business Development & Commercial Excellence, FDC.
Lupin launches generic drug to treat HIV 1 infection
Dr Reddy’s Lab commercially launches 2DG
Dr. Reddy’s Labs launches Icosapent Ethyl Capsules
Cadila Pharma launches Posaconazole to treat fungal diseases
Cipla launches Vitamin C Chewable Tablets with Gold Supplement
Glenmark launches drug to treat Pulmonary disease in UK
Latest Notifications: EC Act (Essential Commodities Act)
NABL: List of NABL Accredited Testing Laboratories
NPPA fixes retail prices of 11 formulations
Fake Syrup supplying Racket busted with one arrest
MBBS interns will have to take Ayush training: NMC
Alert: Various chemicals in Cosmetics: Must read
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
